As these dependency datasets continue to grow, with an emphasis on expanding the representation of nonamplified neuroblastoma lines, we should be able to determine whether this vulnerability is unique or more pronounced in MYCN-amplified compared to MYCN–wild-type neuroblastoma. Here, MYCN is linked to neuroblastoma.